Selective Serotonin Reuptake Inhibitors and their Impact on Bone Health: A Case Report and Literature Review.
- Resource Type
- Article
- Authors
- Ruff, Shannon; Mazharuddin, Mohammad
- Source
- British Journal of Medical Practitioners. Dec2020, Vol. 13 Issue 2, p12-15. 4p.
- Subject
- *SEROTONIN uptake inhibitors
*LITERATURE reviews
*OSTEOPOROSIS
*BONES
*DRUG prescribing
- Language
- ISSN
- 1757-8515
Selective serotonin reuptake inhibitors (SSRIs) are the commonest class of drug prescribed in the management of anxiety and depression. The array of co-morbidities that occur in the elderly population can lead to difficulties in prescribing for depression. Here we present a case report and brief review of the current evidence surrounding SSRIs and their impact on bone health. On the basis of this paper, we suggest caution when prescribing SSRIs in those with osteoporosis, or in those that are at high risk of falls, due to an increased fracture risk in SSRI users compared to non-users. [ABSTRACT FROM AUTHOR]